Received Oct 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA MNEXSPIKE)) | MODERNA | UNK | — | — |
the pharmacist told her that another female patient had "the same thing".; This spontaneous case was reported by a consumer and describes the occurrence of CELLULITIS (the pharmacist told her that another female patient had "the same thing".) in a female patient of an unknown age who received mRNA-1283 (MNEXSPIKE PFS) for COVID-19 prophylaxis. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1283 (MNEXSPIKE PFS) (unknown route) 1 dosage form. On an unknown date, the patient experienced CELLULITIS (the pharmacist told her that another female patient had "the same thing".). At the time of the report, CELLULITIS (the pharmacist told her that another female patient had "the same thing".) outcome was unknown. No concomitant medication was reported. The pharmacist reported that there was another female patient had the same thing. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported. Reporter causality not provided. This case was linked to US-MODERNATX, INC.-MOD-2025-789798 (E2B Linked Report).; Sender's Comments: US-MODERNATX, INC.-MOD-2025-789798:that another female patient had "the same thing"